According to the above, the transformation of plasma cells into malignant cells, the accumulation of M protein, and the presence of genetic mutations and epigenetic alterations constitute the molecular pillars that explain the evolution of PCM, its therapeutic resistance, and its capacity to affect vital organs. Here, MYOM2 is linked to paracoccidioidomycosis.